Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

NCT01398462

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

NCT00086125

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • University of Chicago Hospitals, Section of Hematology/Oncology Chicago, Illinois, United States
  • Washington University School of Medicine, Siteman Cancer Center, 4921 Parkview Place St Louis, Missouri, United States
  • The Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • New York Presbyterian Hospital, Weill College of Cornell University New York, United States
View Trial Details
Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • Novartis Investigative Site Cardiff, Wales, United Kingdom
  • Novartis Investigative Site Bournemouth, United Kingdom
  • Novartis Investigative Site East Yorkshire, United Kingdom
  • Novartis Investigative Site Edinburgh, United Kingdom
View Trial Details

Related conditions